Bristol Myers Squibb has expanded its collaboration with Anthropic to deploy the Claude AI system across multiple pharmaceutical functions, including research, manufacturing, quality monitoring, and regulatory workflows. The move reflects a broader industry shift toward AI-driven operations, but experts warn
